The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Transaction in Own Shares

8 Feb 2019 09:46

RNS Number : 4969P
NB Distressed Debt Invest. Fd. Ltd
08 February 2019
 

NB Distressed Debt Investment Fund Limited (the "Company")

 

Transaction in own Shares - Replacement

 

The following amendment has been made to the 'Transaction in own Shares' announcement released on 7 February 2019 at 07:00.

 

"10,000 New Global Shares at a price of 0.7969 pence" has been amended to "10,000 New Global Shares at a price of 79.69 pence".

 

All other details remain unchanged.

 

The full amended text is shown below.

 

 

 

7 February 2019

 

NB Distressed Debt Investment Fund Limited

(the "Company")

 

 

Transaction in Own Shares

 

 

The Company announces that pursuant to the general authority granted by shareholders of the Company on 19 June 2018 to make market purchases of its own New Global ordinary share capital ("New Global Shares") and of its own Extended Life ordinary share capital ("Extended Life Shares"), it repurchased 10,000 New Global Shares at a price of 79.69 pence per New Global Share, to be cancelled, on 6 February 2019. The Company also repurchased 30,000 Extended Life Shares at a price of $0.8700 per Extended Life Share, to be cancelled, on 6 February 2019. This represents approximately 0.012 per cent of the Company's current issued New Global Shares and approximately 0.0196 per cent of the Company's current issued Extended Life Shares.

 

Following this transaction, the Company has 82,630,361 New Global Shares in issue and 153,324,598 Extended Life Shares in issue. The Company also has 23,395,578 Ordinary Shares in issue. All shares have 1 vote per share.

 

For reporting purposes under the FCA's Disclosure Guidance and Transparency Rules the market should use the figure of 259,350,537 total voting rights when determining if they are required to notify their interest in, or a change to their interest in the Company.

 

 

Enquiries:

 

Carey

Sara Bourne

Tel: +44 (0) 1481 737 245

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSSSESUAFUSELE

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.